News Industry News New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active March 21, 2018
News Industry News Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System March 20, 2018
News Industry News Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform March 05, 2018
News Industry News Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels February 26, 2018
News Industry News AtriCure Launches the AtriClip® FLEX•V™ Device in the United States February 23, 2018
News Industry News Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark February 20, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Industry News Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc. January 24, 2018
News Industry News Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin January 22, 2018
News Industry News Positive Five-Year Data Published for MiStent in EuroIntervention January 12, 2018
News Industry News The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial December 06, 2017
News Industry News Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System November 30, 2017
News Industry News Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure November 14, 2017
News Industry News New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery November 14, 2017
News Industry News Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death October 02, 2017